Last 12 months
Inside the activity.
0 purchase rows · 16 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 15 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 01, 2024 Filed Nov 5, 2024 21:15 UTC |
ANG ROBERTDirector · PRESIDENT AND CEO
|
Tax withholdingCommon Stock | 2,751 | $0.80 | $2,200.80 |
DisclosureSEC source: 0001415889-24-026126 · form4-11052024_041109.xml · nonDerivative · entry 1 ANG ROBERT · CIK 0001741283 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 789,848 F1 · shares: Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 16:17 UTC |
Choi Han WookChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 400,000 | $0.00 Strike: $0.70 | $0.00 |
DisclosureSEC source: 0001415889-24-024389 · form4-10022024_081024.xml · derivative · entry 1 Choi Han Wook · CIK 0002038629 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2034-09-29 F1 · derivative.exercise_date: 1/4th of the shares underlying the option vest on September 30, 2025, with the remainder vesting in equal monthly installments at the end of the each month thereafter over 3 years, in each case subject to the Reporting Person's continued service as of each such date. Read SEC document |
| September 03, 2024 Filed Sep 4, 2024 16:15 UTC |
Quinlan AmyVice President of Finance
|
Tax withholdingCommon Stock | 4,402 | $0.83 | $3,653.66 |
DisclosureSEC source: 0001415889-24-022767 · form4-09042024_040911.xml · nonDerivative · entry 3 Quinlan Amy · CIK 0002027706 · Vice President of Finance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,861 F1 · shares: Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units. Read SEC document |
| September 03, 2024 Filed Sep 4, 2024 20:15 UTC |
ANG ROBERTDirector · PRESIDENT AND CEO
|
Tax withholdingCommon Stock | 12,657 | $0.83 | $10,505.31 |
DisclosureSEC source: 0001415889-24-022768 · form4-09042024_040914.xml · nonDerivative · entry 1 ANG ROBERT · CIK 0001741283 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 792,599 F1 · shares: Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units. Read SEC document |
| September 03, 2024 Filed Sep 4, 2024 20:15 UTC |
Chakraborty TirthaCHIEF SCIENTIFIC OFFICER
|
Tax withholdingCommon Stock | 5,576 | $0.83 | $4,628.08 |
DisclosureSEC source: 0001415889-24-022770 · form4-09042024_040916.xml · nonDerivative · entry 1 Chakraborty Tirtha · CIK 0001840685 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 171,796 F1 · shares: Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units. Read SEC document |
| August 06, 2024 Filed Aug 8, 2024 20:33 UTC |
Attar Eyal C.CHIEF MEDICAL OFFICER
|
Tax withholdingCommon Stock | 999 | $0.87 | $869.13 |
DisclosureSEC source: 0001415889-24-020992 · form4-08082024_080858.xml · nonDerivative · entry 1 Attar Eyal C. · CIK 0001789076 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,918 F1 · shares: Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units. Read SEC document |
| August 06, 2024 Filed Aug 8, 2024 20:30 UTC |
ANG ROBERTDirector · PRESIDENT AND CEO
|
Tax withholdingCommon Stock | 2,361 | $0.87 | $2,054.07 |
DisclosureSEC source: 0001415889-24-020990 · form4-08082024_080840.xml · nonDerivative · entry 1 ANG ROBERT · CIK 0001741283 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 805,256 F1 · shares: Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units. Read SEC document |
| August 06, 2024 Filed Aug 8, 2024 20:29 UTC |
Chakraborty TirthaCHIEF SCIENTIFIC OFFICER
|
Tax withholdingCommon Stock | 876 | $0.87 | $762.12 |
DisclosureSEC source: 0001415889-24-020987 · form4-08082024_080826.xml · nonDerivative · entry 1 Chakraborty Tirtha · CIK 0001840685 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 177,372 F1 · shares: Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units. Read SEC document |
| August 06, 2024 Filed Sep 4, 2024 16:15 UTC |
Quinlan AmyVice President of Finance
|
Tax withholdingCommon Stock | 206 | $0.87 | $179.22 |
DisclosureSEC source: 0001415889-24-022767 · form4-09042024_040911.xml · nonDerivative · entry 2 Quinlan Amy · CIK 0002027706 · Vice President of Finance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,263 F1 · shares: Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units. Read SEC document |
| August 01, 2024 Filed Aug 5, 2024 20:15 UTC |
ANG ROBERTDirector · PRESIDENT AND CEO
|
Tax withholdingCommon Stock | 2,751 | $0.94 | $2,585.94 |
DisclosureSEC source: 0001415889-24-020739 · form4-08052024_040812.xml · nonDerivative · entry 1 ANG ROBERT · CIK 0001741283 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 807,617 F1 · shares: Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units. Read SEC document |
| August 01, 2024 Filed Aug 5, 2024 20:15 UTC |
Attar Eyal C.CHIEF MEDICAL OFFICER
|
Tax withholdingCommon Stock | 1,146 | $0.94 | $1,077.24 |
DisclosureSEC source: 0001415889-24-020738 · form4-08052024_040809.xml · nonDerivative · entry 1 Attar Eyal C. · CIK 0001789076 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,917 F1 · shares: Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units. Read SEC document |
| August 01, 2024 Filed Aug 5, 2024 20:15 UTC |
Chakraborty TirthaCHIEF SCIENTIFIC OFFICER
|
Tax withholdingCommon Stock | 985 | $0.94 | $925.90 |
DisclosureSEC source: 0001415889-24-020737 · form4-08052024_040806.xml · nonDerivative · entry 1 Chakraborty Tirtha · CIK 0001840685 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 178,248 F1 · shares: Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units. Read SEC document |
| August 01, 2024 Filed Sep 4, 2024 16:15 UTC |
Quinlan AmyVice President of Finance
|
Tax withholdingCommon Stock | 343 | $0.94 | $322.42 |
DisclosureSEC source: 0001415889-24-022767 · form4-09042024_040911.xml · nonDerivative · entry 1 Quinlan Amy · CIK 0002027706 · Vice President of Finance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,469 F1 · shares: Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units. Read SEC document |
| June 03, 2024 Filed Jun 4, 2024 22:09 UTC |
Attar Eyal C.CHIEF MEDICAL OFFICER
|
SaleCommon Stock | 14,645 | $1.39 | $20,356.55 |
DisclosureSEC source: 0001415889-24-015450 · form4-06042024_100605.xml · nonDerivative · entry 1 Attar Eyal C. · CIK 0001789076 · CHIEF MEDICAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 96,063 F1 · kind: The transaction was pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.31 to $1.47 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 23, 2024 Filed May 28, 2024 20:10 UTC |
Namouni FouadDirector
|
GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $1.61 | $0.00 |
DisclosureSEC source: 0001415889-24-014651 · form4-05282024_040524.xml · derivative · entry 1 Namouni Fouad · CIK 0001815851 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2034-05-22 F1 · derivative.exercise_date: This option was granted to the Reporting Person pursuant to the Issuer's non-employee director compensation policy. The shares underlying the option vest and become exercisable on the earlier of (i) May 23, 2025 or (ii) the Issuer's next annual meeting of stockholders following the grant date, in each case, subject to the Reporting Person's continued service as a director through such date. Read SEC document |
| May 23, 2024 Filed May 28, 2024 20:10 UTC |
Beckman DaniellaDirector
|
GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $1.61 | $0.00 |
DisclosureSEC source: 0001415889-24-014650 · form4-05282024_040520.xml · derivative · entry 1 Beckman Daniella · CIK 0001513422 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2034-05-22 F1 · derivative.exercise_date: This option was granted to the Reporting Person pursuant to the Issuer's non-employee director compensation policy. The shares underlying the option vest and become exercisable on the earlier of (i) May 23, 2025 or (ii) the Issuer's next annual meeting of stockholders following the grant date, in each case, subject to the Reporting Person's continued service as a director through such date. Read SEC document |
| May 23, 2024 Filed May 28, 2024 20:10 UTC |
Lundberg Sven AnteDirector
|
GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $1.61 | $0.00 |
DisclosureSEC source: 0001415889-24-014649 · form4-05282024_040517.xml · derivative · entry 1 Lundberg Sven Ante · CIK 0001682126 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2034-05-22 F1 · derivative.exercise_date: This option was granted to the Reporting Person pursuant to the Issuer's non-employee director compensation policy. The shares underlying the option vest and become exercisable on the earlier of (i) May 23, 2025 or (ii) the Issuer's next annual meeting of stockholders following the grant date, in each case, subject to the Reporting Person's continued service as a director through such date. Read SEC document |
| May 23, 2024 Filed May 28, 2024 20:10 UTC |
Lubner David CharlesDirector
|
GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $1.61 | $0.00 |
DisclosureSEC source: 0001415889-24-014648 · form4-05282024_040514.xml · derivative · entry 1 Lubner David Charles · CIK 0001572000 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2034-05-22 F1 · derivative.exercise_date: This option was granted to the Reporting Person pursuant to the Issuer's non-employee director compensation policy. The shares underlying the option vest and become exercisable on the earlier of (i) May 23, 2025 or (ii) the Issuer's next annual meeting of stockholders following the grant date, in each case, subject to the Reporting Person's continued service as a director through such date. Read SEC document |
| May 23, 2024 Filed May 28, 2024 20:10 UTC |
Patterson Matthew RDirector
|
GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $1.61 | $0.00 |
DisclosureSEC source: 0001415889-24-014647 · form4-05282024_040511.xml · derivative · entry 1 Patterson Matthew R · CIK 0001401018 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2034-05-22 F1 · derivative.exercise_date: This option was granted to the Reporting Person pursuant to the Issuer's non-employee director compensation policy. The shares underlying the option vest and become exercisable on the earlier of (i) May 23, 2025 or (ii) the Issuer's next annual meeting of stockholders following the grant date, in each case, subject to the Reporting Person's continued service as a director through such date. Read SEC document |
| May 23, 2024 Filed May 28, 2024 20:10 UTC |
Resnick JoshuaDirector
|
GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $1.61 | $0.00 |
DisclosureSEC source: 0001415889-24-014646 · form4-05282024_040508.xml · derivative · entry 1 Resnick Joshua · CIK 0001690959 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2034-05-22 F1 · derivative.exercise_date: This option was granted to the Reporting Person pursuant to the Issuer's non-employee director compensation policy. The shares underlying the option vest and become exercisable on the earlier of (i) May 23, 2025 or (ii) the Issuer's next annual meeting of stockholders following the grant date, in each case, subject to the Reporting Person's continued service as a director through such date. F2 · ownership.direct: Under the Reporting Person's arrangement with RA Capital Management, L.P. (the "Adviser"), the Reporting Person holds the option for the benefit of the RA Capital Healthcare Fund, L.P. (the "Fund") and the RA Capital Nexus Fund, L.P. (the "Nexus Fund"). The Reporting Person is obligated to turn over to the Adviser any net cash or stock received from the option, which will offset advisory fees owed by the Fund and the Nexus Fund to the Adviser. The Reporting Person therefore disclaims beneficial ownership of the option and underlying common stock. Read SEC document |
| May 23, 2024 Filed May 28, 2024 20:10 UTC |
RA CAPITAL MANAGEMENT, L.P.Director · 10% owner
RA Capital Healthcare Fund LPDirector · 10% owner
RA Capital Nexus Fund, L.P.Director · 10% owner
Kolchinsky PeterDirector · 10% owner
Shah Rajeev M.Director · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $1.61 | $0.00 |
DisclosureSEC source: 0001415889-24-014645 · form4-05282024_040502.xml · derivative · entry 1 RA CAPITAL MANAGEMENT, L.P. · CIK 0001346824 · Director · 10% owner RA Capital Healthcare Fund LP · CIK 0001315082 · Director · 10% owner RA Capital Nexus Fund, L.P. · CIK 0001780117 · Director · 10% owner Kolchinsky Peter · CIK 0001384859 · Director · 10% owner Shah Rajeev M. · CIK 0001619841 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2034-05-22 F1 · derivative.exercise_date: This option was granted to Joshua Resnick pursuant to the Issuer's non-employee director compensation policy. The shares underlying the option vest and become exercisable on the earlier of (i) May 23, 2025 or (ii) the Issuer's next annual meeting of stockholders following the grant date, in each case, subject to Mr. Resnick's continued service as a director through such date. F1 · ownership.nature: This option was granted to Joshua Resnick pursuant to the Issuer's non-employee director compensation policy. The shares underlying the option vest and become exercisable on the earlier of (i) May 23, 2025 or (ii) the Issuer's next annual meeting of stockholders following the grant date, in each case, subject to Mr. Resnick's continued service as a director through such date. F2 · ownership.nature: RA Capital Management, L.P. (the "Adviser") is the investment manager for RA Capital Healthcare Fund, L.P. (the "Fund") and RA Capital Nexus Fund, L.P. (the "Nexus Fund"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky, and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein. F3 · ownership.nature: Under Mr. Resnick's arrangement with the Adviser, Mr. Resnick holds the option for the benefit of the Fund and the Nexus Fund. Mr. Resnick is obligated to turn over to the Adviser any net cash or stock received upon exercise of the option, which will offset advisory fees owed by the Fund and the Nexus Fund to the Adviser. The Reporting Persons therefore disclaim beneficial ownership of the option and underlying common stock. Read SEC document |
| May 06, 2024 Filed May 7, 2024 20:15 UTC |
Jorgensen Nathan D.CHIEF FINANCIAL OFFICER
|
Tax withholdingCommon Stock | 834 | $1.75 | $1,459.50 |
DisclosureSEC source: 0001415889-24-012459 · form4-05072024_040508.xml · nonDerivative · entry 1 Jorgensen Nathan D. · CIK 0001842523 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 189,403 F1 · shares: Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units. Read SEC document |
| May 06, 2024 Filed May 7, 2024 20:15 UTC |
Attar Eyal C.CHIEF MEDICAL OFFICER
|
Tax withholdingCommon Stock | 999 | $1.75 | $1,748.25 |
DisclosureSEC source: 0001415889-24-012460 · form4-05072024_040519.xml · nonDerivative · entry 1 Attar Eyal C. · CIK 0001789076 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,708 F1 · shares: Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units. Read SEC document |
| May 06, 2024 Filed May 7, 2024 20:15 UTC |
Chakraborty TirthaCHIEF SCIENTIFIC OFFICER
|
Tax withholdingCommon Stock | 875 | $1.75 | $1,531.25 |
DisclosureSEC source: 0001415889-24-012458 · form4-05072024_040505.xml · nonDerivative · entry 1 Chakraborty Tirtha · CIK 0001840685 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 179,233 F1 · shares: Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units. Read SEC document |
| May 06, 2024 Filed May 7, 2024 20:15 UTC |
ANG ROBERTDirector · PRESIDENT AND CEO
|
Tax withholdingCommon Stock | 2,361 | $1.75 | $4,131.75 |
DisclosureSEC source: 0001415889-24-012457 · form4-05072024_040501.xml · nonDerivative · entry 1 ANG ROBERT · CIK 0001741283 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 810,368 F1 · shares: Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units. Read SEC document |
| May 01, 2024 Filed May 3, 2024 20:15 UTC |
Jorgensen Nathan D.CHIEF FINANCIAL OFFICER
|
Tax withholdingCommon Stock | 917 | $1.77 | $1,623.09 |
DisclosureSEC source: 0001415889-24-012157 · form4-05032024_040516.xml · nonDerivative · entry 1 Jorgensen Nathan D. · CIK 0001842523 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 190,237 F1 · shares: Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units. Read SEC document |
| May 01, 2024 Filed May 3, 2024 20:15 UTC |
ANG ROBERTDirector · PRESIDENT AND CEO
|
Tax withholdingCommon Stock | 2,751 | $1.77 | $4,869.27 |
DisclosureSEC source: 0001415889-24-012155 · form4-05032024_040507.xml · nonDerivative · entry 1 ANG ROBERT · CIK 0001741283 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 812,729 F1 · shares: Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units. Read SEC document |
| May 01, 2024 Filed May 3, 2024 20:15 UTC |
Chakraborty TirthaCHIEF SCIENTIFIC OFFICER
|
Tax withholdingCommon Stock | 985 | $1.77 | $1,743.45 |
DisclosureSEC source: 0001415889-24-012156 · form4-05032024_040512.xml · nonDerivative · entry 1 Chakraborty Tirtha · CIK 0001840685 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 180,108 F1 · shares: Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units. Read SEC document |
| May 01, 2024 Filed May 3, 2024 20:15 UTC |
Attar Eyal C.CHIEF MEDICAL OFFICER
|
Tax withholdingCommon Stock | 1,146 | $1.77 | $2,028.42 |
DisclosureSEC source: 0001415889-24-012159 · form4-05032024_040525.xml · nonDerivative · entry 1 Attar Eyal C. · CIK 0001789076 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,707 F1 · shares: Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units. Read SEC document |
| April 30, 2024 Filed May 2, 2024 20:40 UTC |
Namouni FouadDirector
|
GrantStock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $1.72 | $0.00 |
DisclosureSEC source: 0001415889-24-012004 · form4-05022024_080527.xml · derivative · entry 1 Namouni Fouad · CIK 0001815851 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2034-04-29 F1 · derivative.exercise_date: The shares shall vest and become exercisable in a series of 36 successive equal monthly installments beginning on April 30, 2024, in each case subject to the Reporting Person's continued service as of each such date. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:15 UTC |
Jorgensen Nathan D.CHIEF FINANCIAL OFFICER
|
Tax withholdingCommon Stock | 6,310 | $2.27 | $14,323.70 |
DisclosureSEC source: 0001415889-24-006594 · form4-03052024_040329.xml · nonDerivative · entry 1 Jorgensen Nathan D. · CIK 0001842523 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 191,154 F1 · shares: Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:15 UTC |
Chakraborty TirthaCHIEF SCIENTIFIC OFFICER
|
Tax withholdingCommon Stock | 5,576 | $2.27 | $12,657.52 |
DisclosureSEC source: 0001415889-24-006593 · form4-03052024_040326.xml · nonDerivative · entry 1 Chakraborty Tirtha · CIK 0001840685 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 181,093 F1 · shares: Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:15 UTC |
ANG ROBERTDirector · PRESIDENT AND CEO
|
Tax withholdingCommon Stock | 12,657 | $2.27 | $28,731.39 |
DisclosureSEC source: 0001415889-24-006592 · form4-03052024_040323.xml · nonDerivative · entry 1 ANG ROBERT · CIK 0001741283 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 815,480 F1 · shares: Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 22:06 UTC |
Jorgensen Nathan D.CHIEF FINANCIAL OFFICER
|
Tax withholdingCommon Stock | 985 | $2.32 | $2,285.20 |
DisclosureSEC source: 0001415889-24-003036 · form4-02082024_100233.xml · nonDerivative · entry 1 Jorgensen Nathan D. · CIK 0001842523 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 197,464 F1 · shares: Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 22:10 UTC |
Attar Eyal C.CHIEF MEDICAL OFFICER
|
Tax withholdingCommon Stock | 1,180 | $2.32 | $2,737.60 |
DisclosureSEC source: 0001415889-24-003041 · form4-02082024_100231.xml · nonDerivative · entry 1 Attar Eyal C. · CIK 0001789076 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,853 F1 · shares: Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 22:08 UTC |
ANG ROBERTDirector · PRESIDENT AND CEO
|
Tax withholdingCommon Stock | 2,788 | $2.32 | $6,468.16 |
DisclosureSEC source: 0001415889-24-003038 · form4-02082024_100240.xml · nonDerivative · entry 1 ANG ROBERT · CIK 0001741283 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 828,137 F1 · shares: Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 22:05 UTC |
Chakraborty TirthaCHIEF SCIENTIFIC OFFICER
|
Tax withholdingCommon Stock | 1,033 | $2.32 | $2,396.56 |
DisclosureSEC source: 0001415889-24-003033 · form4-02082024_100204.xml · nonDerivative · entry 1 Chakraborty Tirtha · CIK 0001840685 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 186,669 F1 · shares: Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units. Read SEC document |
| January 29, 2024 Filed Feb 1, 2024 00:34 UTC |
Jorgensen Nathan D.CHIEF FINANCIAL OFFICER
|
GrantEmployee Stock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $2.41 | $0.00 |
DisclosureSEC source: 0001415889-24-002096 · form4-02012024_120227.xml · derivative · entry 2 Jorgensen Nathan D. · CIK 0001842523 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2034-01-28 F3 · derivative.exercise_date: The shares shall vest and become exercisable in a series of 48 successive equal monthly installments beginning on February 1, 2024, in each case subject to the Reporting Person's continued service as of each such date. Read SEC document |
| January 29, 2024 Filed Feb 1, 2024 00:34 UTC |
Jorgensen Nathan D.CHIEF FINANCIAL OFFICER
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-002096 · form4-02012024_120227.xml · nonDerivative · entry 1 Jorgensen Nathan D. · CIK 0001842523 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 198,449 F1 · shares: Represents the number of shares underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs vest over four years in equal quarterly installments beginning on February 1, 2024, subject to the Reporting Person's continued service as of each such date. F2 · balance_after: Includes 2,802 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan. Read SEC document |
| January 29, 2024 Filed Feb 1, 2024 00:38 UTC |
Attar Eyal C.CHIEF MEDICAL OFFICER
|
GrantEmployee Stock Option (right to buy) · Derivative | 125,000 | $0.00 Strike: $2.41 | $0.00 |
DisclosureSEC source: 0001415889-24-002104 · form4-02012024_120200.xml · derivative · entry 2 Attar Eyal C. · CIK 0001789076 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2034-01-28 F2 · derivative.exercise_date: The shares shall vest and become exercisable in a series of 48 successive equal monthly installments beginning on February 1, 2024, in each case subject to the Reporting Person's continued service as of each such date. Read SEC document |
| January 29, 2024 Filed Feb 1, 2024 00:38 UTC |
Attar Eyal C.CHIEF MEDICAL OFFICER
|
GrantCommon Stock | 62,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-002104 · form4-02012024_120200.xml · nonDerivative · entry 1 Attar Eyal C. · CIK 0001789076 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,033 F1 · shares: Represents the number of shares underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs vest over four years in equal quarterly installments beginning on February 1, 2024, subject to the Reporting Person's continued service as of each such date. Read SEC document |
| January 29, 2024 Filed Feb 1, 2024 00:36 UTC |
Chakraborty TirthaCHIEF SCIENTIFIC OFFICER
|
GrantEmployee Stock Option (right to buy) · Derivative | 107,500 | $0.00 Strike: $2.41 | $0.00 |
DisclosureSEC source: 0001415889-24-002101 · form4-02012024_120240.xml · derivative · entry 2 Chakraborty Tirtha · CIK 0001840685 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,500 Underlying: Common Stock · 107,500 shares Expires 2034-01-28 F2 · derivative.exercise_date: The shares shall vest and become exercisable in a series of 48 successive equal monthly installments beginning on February 1, 2024, in each case subject to the Reporting Person's continued service as of each such date. Read SEC document |
| January 29, 2024 Filed Feb 1, 2024 00:36 UTC |
Chakraborty TirthaCHIEF SCIENTIFIC OFFICER
|
GrantCommon Stock | 53,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-002101 · form4-02012024_120240.xml · nonDerivative · entry 1 Chakraborty Tirtha · CIK 0001840685 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 187,702 F1 · shares: Represents the number of shares underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs vest over four years in equal quarterly installments beginning on February 1, 2024, subject to the Reporting Person's continued service as of each such date. Read SEC document |
| January 29, 2024 Filed Feb 1, 2024 00:35 UTC |
ANG ROBERTDirector · PRESIDENT AND CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 470,000 | $0.00 Strike: $2.41 | $0.00 |
DisclosureSEC source: 0001415889-24-002098 · form4-02012024_120236.xml · derivative · entry 2 ANG ROBERT · CIK 0001741283 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 470,000 Underlying: Common Stock · 470,000 shares Expires 2034-01-28 F2 · derivative.exercise_date: The shares shall vest and become exercisable in a series of 48 successive equal monthly installments beginning on February 1, 2024, in each case subject to the Reporting Person's continued service as of each such date. Read SEC document |
| January 29, 2024 Filed Feb 1, 2024 00:35 UTC |
ANG ROBERTDirector · PRESIDENT AND CEO
|
GrantCommon Stock | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-002098 · form4-02012024_120236.xml · nonDerivative · entry 1 ANG ROBERT · CIK 0001741283 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 830,925 F1 · shares: Represents the number of shares underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs vest over four years in equal quarterly installments beginning on February 1, 2024, subject to the Reporting Person's continued service as of each such date. Read SEC document |
| November 06, 2023 Filed Nov 8, 2023 21:12 UTC |
Jorgensen Nathan D.Chief Financial Officer
|
Tax withholdingCommon Stock | 834 | $1.82 | $1,517.88 |
DisclosureSEC source: 0001209191-23-054696 · doc4.xml · nonDerivative · entry 1 Jorgensen Nathan D. · CIK 0001842523 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,647 F1 · shares: Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units. Read SEC document |
| November 06, 2023 Filed Nov 8, 2023 21:14 UTC |
Chakraborty TirthaChief Scientific Officer
|
Tax withholdingCommon Stock | 876 | $1.82 | $1,594.32 |
DisclosureSEC source: 0001209191-23-054702 · doc4.xml · nonDerivative · entry 1 Chakraborty Tirtha · CIK 0001840685 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,952 F1 · shares: Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units. Read SEC document |
| November 06, 2023 Filed Nov 8, 2023 21:13 UTC |
ANG ROBERTDirector · President and CEO
|
Tax withholdingCommon Stock | 2,361 | $1.82 | $4,297.02 |
DisclosureSEC source: 0001209191-23-054699 · doc4.xml · nonDerivative · entry 1 ANG ROBERT · CIK 0001741283 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 680,925 F1 · shares: Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units. Read SEC document |
| November 06, 2023 Filed Nov 8, 2023 21:10 UTC |
Attar Eyal C.Chief Medical Officer
|
Tax withholdingCommon Stock | 999 | $1.82 | $1,818.18 |
DisclosureSEC source: 0001209191-23-054692 · doc4.xml · nonDerivative · entry 1 Attar Eyal C. · CIK 0001789076 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,533 F1 · shares: Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 20:31 UTC |
Jorgensen Nathan D.Chief Financial Officer
|
Tax withholdingCommon Stock | 6,310 | $2.67 | $16,847.70 |
DisclosureSEC source: 0001209191-23-048387 · doc4.xml · nonDerivative · entry 1 Jorgensen Nathan D. · CIK 0001842523 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 146,481 F1 · shares: Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.